COMPUGROUP MEDICAL SE & CO. KGAA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 6th Interim Announcement, concurrently Completion Announcement

01/10/2022 | 12:55pm EDT

DGAP Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-Back Program
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 6th Interim Announcement, concurrently Completion Announcement

10.01.2022 / 18:53
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052

CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 6th Interim Announcement, concurrently Completion Announcement

In the period from January 03, 2022 until and including January 10, 2022, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 96,122 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on November 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on November 26, 2021.

The aggregate number of shares bought back each day during the period from January 03, 2022 until and including January 10, 2022 as well as the daily volume-weighted average prices for such buy-backs are as follows:

Date Aggregate volume (number of no-par value shares) Volume-weighted average price (in EUR, excluding ancillary costs and charges)
January 03, 2022 18,601 71.7335
January 04, 2022 17,760 69.5729
January 05, 2022 18,526 65.9024
January 06, 2022 19,150 63.7060
January 07, 2022 18,356 63.2598
January 10, 2022 3.729 62.7137
Total: 96,122 66.6431
 

The aggregate number of shares bought back within the share buy-back program in the period from November 26, 2021 until and including January 10, 2022 amounts to 500,000 shares. The maximum number of shares to be bought back under the share buy-back program has been reached on January 10, 2022 and the share buy-back program is therefore completed. The purchase price per share paid for the 500,000 shares bought amounted to an average of EUR 67.6705.

Detailed information about the transactions are published on the company's website under www.cgm.com/sbb.

The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading).

Koblenz, January 10, 2022

CompuGroup Medical SE & Co. KGaA
The general partner



10.01.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

 
End of News DGAP News Service

1266961  10.01.2022 

fncls.ssp?fn=show_t_gif&application_id=1266961&application_name=news&site_id=zonebourse_sftp

© EQS 2022
All news about COMPUGROUP MEDICAL SE & CO. KGAA
05/20COMPUGROUP MEDICAL SE & CO. KGAA : Ex-dividend day for final dividend
FA
05/19CompuGroup Medical reports record results at virtual Annual General Meeting and confirm..
EQ
05/19CompuGroup Medical SE & Co. KGaA Provides Revenue Guidance for the Year 2022
CI
05/19COMPUGROUP MEDICAL : Deutsche Bank maintains a Buy rating
MD
05/06COMPUGROUP MEDICAL : Berenberg gives a Buy rating
MD
05/05CompuGroup Medical SE & Co. KGaA Reports Earnings Results for the First Quarter Ended M..
CI
05/05COMPUGROUP MEDICAL : Baader Bank keeps its Buy rating
MD
05/05COMPUGROUP MEDICAL : Baader Bank reiterates its Buy rating
MD
05/05COMPUGROUP MEDICAL : Jefferies remains its Buy rating
MD
05/05COMPUGROUP MEDICAL : Gets a Buy rating from Warburg Research
MD
More news
Analyst Recommendations on COMPUGROUP MEDICAL SE & CO. KGAA
More recommendations
Financials
Sales 2022 1 099 M 1 159 M 1 159 M
Net income 2022 85,8 M 90,5 M 90,5 M
Net Debt 2022 567 M 598 M 598 M
P/E ratio 2022 31,0x
Yield 2022 1,13%
Capitalization 2 620 M 2 764 M 2 764 M
EV / Sales 2022 2,90x
EV / Sales 2023 2,66x
Nbr of Employees 8 210
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SE & CO. KGAA
Duration : Period :
CompuGroup Medical SE & Co. KGaA Technical Analysis Chart | COP | DE000A288904 | MarketScreener
Technical analysis trends COMPUGROUP MEDICAL SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 50,15 €
Average target price 71,45 €
Spread / Average Target 42,5%
EPS Revisions
Managers and Directors
Dirk Wössner Chairman-Management Board & CEO
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas Müller Chief Information Officer
Ulrike Handel Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SE & CO. KGAA-29.52%2 764
ORACLE CORPORATION-21.30%178 873
SAP SE-26.33%111 823
SERVICENOW INC.-33.29%85 548
CONSTELLATION SOFTWARE INC.-16.72%32 336
SENSETIME GROUP INC.-11.64%19 511